» Articles » PMID: 20156100

Genetic Characterization of HIV Type 1 Nef-induced Vesicle Secretion

Overview
Publisher Mary Ann Liebert
Date 2010 Feb 17
PMID 20156100
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The HIV-1 Nef protein is known to be secreted, and our group has shown that Nef is secreted from nef-transfected and HIV-1-infected cells in small exosome-like vesicles (d. 40-100 nm). The role of secreted Nef remains to be fully characterized. Thus, it is important to characterize the nature of and the mechanisms regulating Nef secretion. We hypothesized that specific structural domains on the Nef protein interact with components of the endosomal trafficking machinery, sorting Nef into multivesicular bodies (MVB) and packaging it in exosome-like vesicles. To identify those domains, a series of mutants spanning the entire nef sequence were made and cloned into the expression vector pQB1, which expresses the mutants as Nef-GFP fusion proteins. These constructs were used in transient transfection assays to identify sequences necessary for secretion of the Nef-GFP fusion protein. N-terminal domains were identified as critical for Nef-induced vesicle secretion: (1) a basic cluster of four arginine residues (aa 17, 19, 21, 22), (2) the phosphofurin acidic cluster sequence (PACS; Glu62-65), and (3) a previously uncharacterized domain spanning amino acid residues 66-70 (VGFPV), which we named the secretion modification region (SMR). Additional amino acids P25, 29GVG31, and T44 were identified in HIV-1 Nef as regulating its secretion. These residues have not been associated with other reported Nef functions. The myristoylation domain, ubiquitination lysine residues, and the C-terminal portion of Nef (aa 71-206) had no effect on secretion. A minimal HIV-1 Nef sequence, comprising the identified motifs, was sufficient for Nef-induced vesicle secretion.

Citing Articles

Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes.

Khabir M, Blanchet M, Angelo L, Loucif H, van Grevenynghe J, Bukong T Viruses. 2024; 16(6).

PMID: 38932118 PMC: 11209184. DOI: 10.3390/v16060825.


Exosomes: a promising avenue for cancer diagnosis beyond treatment.

Wang Z, Wang Q, Qin F, Chen J Front Cell Dev Biol. 2024; 12:1344705.

PMID: 38419843 PMC: 10900531. DOI: 10.3389/fcell.2024.1344705.


Exosome-mediated regulation of inflammatory pathway during respiratory viral disease.

Gheitasi H, Sabbaghian M, Shekarchi A, Mirmazhary A, Poortahmasebi V Virol J. 2024; 21(1):30.

PMID: 38273382 PMC: 10811852. DOI: 10.1186/s12985-024-02297-y.


A Review Study of the Participation of Late Domains in Sorting and Transport of Viral Factors to Exosomes.

Velazquez-Cervantes M, Benitez-Zeferino Y, Flores-Pliego A, Helguera-Repetto A, Meza-Sanchez D, Maravillas-Montero J Life (Basel). 2023; 13(9).

PMID: 37763246 PMC: 10532540. DOI: 10.3390/life13091842.


The emerging role of exosomes in innate immunity, diagnosis and therapy.

Gangadaran P, Madhyastha H, Madhyastha R, Rajendran R, Nakajima Y, Watanabe N Front Immunol. 2023; 13:1085057.

PMID: 36726968 PMC: 9885214. DOI: 10.3389/fimmu.2022.1085057.


References
1.
Dickie P . Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice. AIDS Res Hum Retroviruses. 2000; 16(8):777-90. DOI: 10.1089/088922200308774. View

2.
Meziani F, Tesse A, Andriantsitohaina R . Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol Rep. 2008; 60(1):75-84. View

3.
Ledru E, Lecoeur H, Garcia S, Debord T, Gougeon M . Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol. 1998; 160(7):3194-206. View

4.
Gratton S, Cheynier R, Dumaurier M, Oksenhendler E, Wain-Hobson S . Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc Natl Acad Sci U S A. 2000; 97(26):14566-71. PMC: 18959. DOI: 10.1073/pnas.97.26.14566. View

5.
Jekle A, Keppler O, De Clercq E, Schols D, Weinstein M, Goldsmith M . In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J Virol. 2003; 77(10):5846-54. PMC: 154038. DOI: 10.1128/jvi.77.10.5846-5854.2003. View